HK Stock MarketDetailed Quotes
01877 JUNSHI BIO
- 10.400
- -0.540-4.94%
Trading Sep 10 15:20 CST
10.25BMarket Cap-4846P/E (TTM)
10.900High10.380Low999.40KVolume10.900Open10.940Pre Close10.48MTurnover0.46%Turnover RatioLossP/E (Static)985.69MShares24.60052wk High1.44P/B2.28BFloat Cap9.17052wk Low--Dividend TTM219.30MShs Float97.150Historical High--Dividend LFY4.75%Amplitude9.170Historical Low10.488Avg Price200Lot Size--Div YieldTTM--Div Yield LFY
JUNSHI BIO Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 17.37%786.06M | 49.24%380.8M | 3.38%1.5B | -19.04%986.46M | -29.21%669.7M | -59.47%255.15M | -63.89%1.45B | -55.18%1.22B | -55.26%946.05M | -61.02%629.52M |
| Operating income | 17.37%786.06M | 49.24%380.8M | 3.38%1.5B | -19.04%986.46M | -29.21%669.7M | -59.47%255.15M | -63.89%1.45B | -55.18%1.22B | -55.26%946.05M | -61.02%629.52M |
| Cost of sales | 26.94%-210.8M | ---- | -26.79%-667.29M | ---- | 9.97%-288.51M | ---- | 58.17%-526.28M | ---- | 30.92%-320.47M | ---- |
| Operating expenses | 26.94%-210.8M | -26.41%-108.09M | -26.79%-667.29M | 21.17%-336.85M | 9.97%-288.51M | 48.07%-85.51M | 58.17%-526.28M | 43.03%-427.31M | 30.92%-320.47M | 41.29%-164.68M |
| Gross profit | 50.91%575.26M | 60.76%272.71M | -9.92%835.26M | -17.88%649.61M | -39.07%381.19M | -63.51%169.64M | -66.49%927.21M | -59.81%791.07M | -62.10%625.58M | -65.17%464.84M |
| Selling expenses | -14.59%-427.55M | -4.91%-191.59M | -17.98%-844.36M | -7.91%-554.41M | -21.39%-373.13M | -13.69%-182.62M | 2.57%-715.7M | 2.59%-513.77M | 27.27%-307.39M | 40.16%-160.63M |
| Administrative expenses | -4.39%-252.6M | -8.99%-123.31M | 3.71%-556.81M | 14.33%-359.4M | 18.06%-241.97M | 36.74%-113.14M | 10.75%-578.27M | 2.03%-419.52M | 0.07%-295.29M | -8.49%-178.84M |
| Research and development expenses | 42.40%-546.38M | 47.64%-276.29M | 18.74%-1.94B | 22.34%-1.27B | 10.70%-948.6M | -3.28%-527.66M | -15.26%-2.38B | -15.01%-1.64B | -12.14%-1.06B | -13.37%-510.91M |
| Profit from asset sales | ---- | --23.72M | ---- | -98.14%600.42K | ---- | ---- | ---- | 3,894.61%32.2M | ---- | ---- |
| Revaluation surplus | ---- | 81.15%-1.15M | ---- | -174.26%-45.85M | ---- | ---6.12M | ---- | -111.83%-16.72M | ---- | ---- |
| -Changes in the fair value of other assets | ---- | 81.15%-1.15M | ---- | -174.26%-45.85M | ---- | ---6.12M | ---- | -111.83%-16.72M | ---- | ---- |
| Impairment and provision | 1,028.34%10.42M | 143.94%9.01M | -49,865.96%-23.48M | -96.69%-36.36M | -2,836.59%-1.12M | -624.93%-20.52M | -113.74%-47K | -33.83%-18.49M | -92.74%41K | 16.35%-2.83M |
| -Other impairment is provision | 1,028.34%10.42M | 143.94%9.01M | -49,865.96%-23.48M | -96.69%-36.36M | -2,836.59%-1.12M | -624.93%-20.52M | -113.74%-47K | -33.83%-18.49M | -92.74%41K | 16.35%-2.83M |
| Special items of operating profit | -84.30%8.58M | -105.13%-1.84M | -28.30%126.46M | -672.06%-5.84M | -47.17%54.65M | 369.12%35.89M | -10.92%176.38M | -67.98%1.02M | -36.84%103.45M | -25.73%7.65M |
| Operating profit | 44.00%-632.28M | 54.58%-294.39M | 6.77%-2.4B | 8.48%-1.64B | -20.64%-1.13B | -68.61%-648.11M | -429.51%-2.57B | -530.57%-1.79B | -726.17%-935.86M | -184.11%-384.39M |
| Financing cost | -67.67%-24.39M | -89.58%1.55M | 1.24%-29.01M | -22.42%55.34M | -6.20%-14.55M | 129.95%14.89M | -34.52%-29.37M | 1,500.36%71.34M | 39.26%-13.7M | -37.69%6.48M |
| Share of profits of associates | 36.04%-19.35M | ---- | 20.19%-55.45M | ---- | -9.06%-30.25M | ---- | -43.27%-69.48M | ---- | -139.74%-27.74M | ---- |
| Share of profit from joint venture company | -331.60%-8.88M | ---- | -224.58%-5.03M | ---- | -300.19%-2.06M | ---- | -4,528.57%-1.55M | ---- | -51,300.00%-514K | ---- |
| Special items of earning before tax | ---- | 12.32%-3.71M | ---- | -150.28%-27.15M | ---- | -126.16%-4.24M | ---- | 54.31%-10.85M | 30.60%-11.11M | 69.14%-1.87M |
| Earning before tax | 41.75%-684.89M | 53.48%-296.55M | 6.93%-2.49B | 6.91%-1.61B | -18.90%-1.18B | -67.85%-637.45M | -351.40%-2.68B | -452.97%-1.73B | -1,095.63%-988.91M | -182.33%-379.79M |
| Tax | -107.03%-3.55M | -43.05%-3.1M | -147.25%-44M | 782.01%52.39M | 634.45%50.5M | 94.77%-2.17M | 168.70%93.11M | 90.38%-7.68M | 89.36%-9.45M | 50.71%-41.4M |
| After-tax profit from continuing operations | 38.82%-688.45M | 53.15%-299.65M | 1.87%-2.53B | 10.34%-1.56B | -12.72%-1.13B | -51.86%-639.62M | -254.60%-2.58B | -342.34%-1.73B | -9,578.40%-998.36M | -211.63%-421.19M |
| Earning after tax | 38.82%-688.45M | 53.15%-299.65M | 1.87%-2.53B | 10.34%-1.56B | -12.72%-1.13B | -51.86%-639.62M | -254.60%-2.58B | -342.34%-1.73B | -9,578.40%-998.36M | -211.63%-421.19M |
| Minority profit | 66.84%-42.75M | 82.72%-16.62M | -28.68%-252.26M | -6.08%-148.31M | -48.13%-128.92M | -287.96%-96.19M | -1,936.87%-196.03M | -47,495,955.67%-139.81M | -8,703,000.00%-87.03M | -8,446,434.94%-24.79M |
| Profit attributable to shareholders | 35.20%-645.69M | 47.92%-283.03M | 4.38%-2.28B | 11.78%-1.41B | -9.34%-996.42M | -37.09%-543.43M | -232.06%-2.39B | -306.69%-1.59B | -8,751.31%-911.33M | -205.06%-396.4M |
| Basic earnings per share | 34.65%-0.66 | 47.27%-0.29 | 10.77%-2.32 | 18.29%-1.43 | -1.00%-1.01 | -25.00%-0.55 | -225.00%-2.6 | -297.73%-1.75 | -10,100.00%-1 | -202.33%-0.44 |
| Diluted earnings per share | 34.65%-0.66 | 47.27%-0.29 | 10.77%-2.32 | 18.29%-1.43 | -1.00%-1.01 | -25.00%-0.55 | -225.00%-2.6 | -297.73%-1.75 | -10,100.00%-1 | -202.33%-0.44 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) | IAS | CAS (2007) |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
| Auditor | -- | -- | Huapu Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- | Huapu Tianjian Certified Public Accountants (Special General Partnership) | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg